Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Teucrium Soybean Fund (SOYB) vs Vertex Pharmaceuticals Incorporated (VRTX) Price & Performance

Teucrium Soybean FundTrade
Vertex Pharmaceuticals IncorporatedTrade

Price performance (Past 24H)

Key statistics

Teucrium Soybean Fund vs Vertex Pharmaceuticals Incorporated — how do they compare? Teucrium Soybean Fund trades at $24.82, while Vertex Pharmaceuticals Incorporated trades at $529.98 (market cap $134.25B). The key difference: Vertex Pharmaceuticals Incorporated is trading nearer its 52-week high, Teucrium Soybean Fund nearer its low. Which is the better fit depends on your goals.

SOYBVRTX
Sector
Commodities - Metals/AgricultureHealth
52-Week High
$26.28$529.65
52-Week Low
$21.46$376.62
Market Cap
$134.25B
Enterprise Value
$128.37B

Returns comparison

Trailing returns across standard periods

About Teucrium Soybean Fund

SOYB is a commodity ETF that provides exposure to the price of soybean futures. It utilizes a laddered strategy by investing in several benchmark futures contracts to reduce the impact of roll costs and contango in the agricultural market.

Read more on SOYB

About Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Read more on VRTX